Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 875,836 $ 1,201,112
Restricted cash 859,898 503,397
Accounts and other receivables 217,925 5,749
Inventory 160,161 18,125
Derivative assets 23,750 3,416
Other current assets 100,748 50,787
Total current assets 2,238,318 1,782,586
Non-current restricted cash 90,819 31,722
Property, plant and equipment, net 20,635,294 16,193,907
Debt issuance costs, net 276,551 378,677
Non-current derivative assets 82,861 30,887
Goodwill 76,819 76,819
Other non-current assets, net 302,075 314,455
Total assets 23,702,737 18,809,053
Current liabilities    
Accounts payable 48,577 22,820
Accrued liabilities 637,097 427,199
Current debt, net 247,467 1,673,379
Deferred revenue 72,631 26,669
Derivative liabilities 70,673 35,201
Other current liabilities 224 0
Total current liabilities 1,076,669 2,185,268
Long-term debt, net 21,687,532 14,920,427
Non-current deferred revenue 5,500 9,500
Non-current derivative liabilities 45,106 79,387
Other non-current liabilities 49,534 53,068
Commitments and contingencies (see Note 19)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at December 31, 2016 and 2015; Issued: 250.1 million shares and 247.3 million shares at December 31, 2016 and 2015, respectively
Outstanding: 238.0 million shares and 235.6 million shares at December 31, 2016 and 2015, respectively 714 708
Treasury stock: 12.2 million shares and 11.6 million shares at December 31, 2016 and 2015, respectively, at cost (374,324) (353,927)
Additional paid-in-capital 3,211,124 3,075,317
Accumulated deficit (4,233,939) (3,623,948)
Total stockholders’ deficit (1,396,425) (901,850)
Non-controlling interest 2,234,821 2,463,253
Total equity 838,396 1,561,403
Total liabilities and equity $ 23,702,737 $ 18,809,053